Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tsetan Dolkar"'
Autor:
Tsering Stobdan, Tsetan Dolkar, Om Prakash Chaurasia, Deepak Kumar, Joginder S. Chandel, Spalzin Angmo
Publikováno v:
Defence Life Science Journal. 6:64-69
Seven local apple cultivars of the trans-Himalayan Ladakh region were studied for phenological and pomological characteristics. Early and extended flowering was observed. Flowering began 12 days earlier as compared to Royal Delicious, a popular intro
Autor:
Michael T. Tetzlaff, Jonathan L. Curry, Phyu P. Aung, Rodabe N. Amaria, Doina Ivan, Priyadharsini Nagarajan, Tsetan Dolkar, Carlos A. Torres-Cabala, Victor G. Prieto, Celestine M Trinidad, Kelly C. Nelson
Publikováno v:
Journal of Cutaneous Pathology. 45:539-544
LL-37 is a naturally occurring 37-amino-acid peptide that is part of the innate immune system in human skin. Preclinical studies have showed that intra-tumoral injections of LL-37 stimulate the innate immune system by activation of plasmacytoid dendr
Publikováno v:
International Journal of Surgical Pathology. 21:215-223
Context. A significant portion of colorectal biopsies are performed for evaluation of polyps or polypoid lesions. Accurately identifying these lesions will promote better patient care. Objective. Review of the pathology of major colon polyps and poly
Publikováno v:
Connecticut medicine. 80(6)
Image-guided core needle biopsy (CNB) is the standard for diagnostic breast biopsy. However, the upgrade rate to a higher order lesion defined as identification of malignancy on final pathology from surgical excision remains problematic.A retrospecti
Publikováno v:
American Journal of Clinical Pathology. 144:A253-A253
Publikováno v:
American Journal of Clinical Pathology. 144:A259-A259
Autor:
Michael Cohenuram, Evgeniya Angelova, Nusrat F. Pathan, Ivan Vinev, Tsetan Dolkar, Jeffrey West
Publikováno v:
American Journal of Clinical Pathology. 142:A123-A123
Publikováno v:
American Journal of Clinical Pathology. 140:A018-A018
Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and 90%-95% of neoplasms arising from the kidney. RCC may remain clinically occult for most of its course. One-third of patients with newly diagnosed RCC will have metasta